Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039886 | SCV000063577 | benign | not specified | 2012-01-24 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000039886 | SCV000114331 | likely benign | not specified | 2015-08-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000039886 | SCV000515094 | benign | not specified | 2015-08-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000473791 | SCV000555179 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000039886 | SCV000616006 | benign | not specified | 2016-10-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001811284 | SCV002048335 | benign | not provided | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839508 | SCV002100038 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839509 | SCV002100039 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839510 | SCV002100040 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839507 | SCV002100041 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000039886 | SCV002571831 | likely benign | not specified | 2022-08-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001811284 | SCV004148130 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BP7 |